Galecto Inc (GLTO)
6.85
-0.04
(-0.58%)
USD |
NASDAQ |
Nov 14, 16:00
6.85
0.00 (0.00%)
After-Hours: 18:31
Galecto Total Assets (Quarterly): 23.38M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 23.38M |
| June 30, 2024 | 27.30M |
| March 31, 2024 | 32.48M |
| December 31, 2023 | 38.23M |
| September 30, 2023 | 50.05M |
| June 30, 2023 | 58.80M |
| March 31, 2023 | 64.63M |
| December 31, 2022 | 73.19M |
| September 30, 2022 | 82.02M |
| June 30, 2022 | 92.86M |
| Date | Value |
|---|---|
| March 31, 2022 | 108.93M |
| December 31, 2021 | 122.22M |
| September 30, 2021 | 135.87M |
| June 30, 2021 | 146.82M |
| March 31, 2021 | 158.66M |
| December 31, 2020 | 171.60M |
| September 30, 2020 | 98.15M |
| June 30, 2020 | 40.96M |
| December 31, 2019 | 56.61M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
23.38M
Minimum
Sep 2024
171.60M
Maximum
Dec 2020
83.30M
Average
73.19M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Novo Nordisk AS | 59.53B |
| Genmab AS | 5.940B |
| Ascendis Pharma AS | 812.82M |
| Evaxion Biotech AS | 15.18M |
| IO Biotech Inc | 111.47M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.441M |
| Shareholders Equity (Quarterly) | 20.94M |